Details
Category: Volume 06 Issue 01 January 2018
Hits: 1246

Title: Surgical Management of Metastatic groin lymphadenopathy-Retrospective study of 50 Cases in Regional Cancer Center

Authors: Dr Ashwathappa Dasappa, Dr S. Krishna Murthy, Dr P.Sridhar, Dr S. Balu, Mr Vijay C.R

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i1.29

Abstract

Introduction: Surgery of malignant disease is not the surgery of organs, it is the anatomy of the lymphatic system. Lymph node metastasis are ‘Indicators, not Governors’ of outcome in every major study of epithelial cancer. Groin dissection has key role in the management of metastatic lymph node disease from primary cancer in the anatomical areas drained by these nodes i.e. Peno-scrotal, vulvo-vaginal, ano-rectal and skin cancers of the infra-umbilical trunk, perineum, buttocks and lower extremities. Tumors associated with these structures are squamous cell carcinoma, malignant melanoma, less frequently adenocarcinoma and sometimes soft tissue sarcoma. Pre operative diagnosis and post operative care of these patients involves the role of general surgeons, urologist, gynecologists and oncologists.

Aims and Objectives

  1. Incidence and severity of post operative morbidity.
  2. Patient related risk factors affecting these morbidity.
  3. Procedure related risk factors affecting these morbidity.

Methods and Materials: This is a retrospective study with sample size of 50 patients, who underwent 70 surgeries for Groin dissection conducted at Kidwai Cancer Institute which is one of the Regional cancer centre from 2013 to 2014.

Results

  • Oblique incisions are associated with decrease infection of wound complications.
  • Synchronous surgery of the primary and groin is the risk factor for wound infection.
  • Patients with pathologically positive groin lymph nodes have increased risk of skin flap problems.

Radical groin lymph node dissection patients had increase rate of lymphedema. 

References

  1. Office for National Statistics. Cancer registration statistics, England 2003. London: ONS, 2003.
  2. Ornellas AA, Seixas AL, Marota A, Wisnescky A, Campos F, de Moraes JR. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 1994;151:1244-9.
  3. Pecorelli S, Benedet JL, Creasman WT, Shepherd JH. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet 1999;65:243-9.
  4. Roses DF, Harris MN, Hidalgo D, Valensi QJ, Dubin N. Primary melanoma thickness correlated with regional lymph node metastases. Arch Surg 1982;117:921-3.
  5. Guarischi A, Keane TJ, Elhakim T. Metastatic inguinal nodes from an unknown primary neoplasm. A review of 56 cases. Cancer 1987;59:572-7.
  6. Basler GC, Fader DJ, Yahanda A, Sondak VK, Johnson TM. The utility of fine needle aspiration in the diagnosis of melanoma metastatic to lymph nodes. J Am Acad Dermatol 1997;36:403-8.
  7. Van der Velden J, Ansink A. Primary groin irradiation vs primary groin surgery for early vulvar cancer. Cochrane Library, Issue 2, 2004. Chichester: John Wiley.
  8. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 1998;351:793-6.
  9. Balch CM, Soong SJ, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255-63.
  10. Roberts DL, Anstey AV, Barlow RJ, Cox NH, Newton Bishop JA, Corrie PG, et al.U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol 2002;146:7-17.
  11. Hettiaratchy SP, Kang N, O’Toole G, Allan R, Cook MG, Powell BWEM. Sentinel lymph node biopsy in malignant melanoma: a series of 100 consecutive cases. Br J Plast Surg 2000;53:559-62.
  12. Cascinelli N, Belli F, Santinami M, Fait V, Testori A, RukaW, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO melanoma program experience. Ann Surg Oncol 2000;7:469-74.
  13. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-48.
  14. Kretschmer L, Hilgers R, Mohrle M, Balda BR, Breuniger H, Konz B, et al. Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphanodectomy and early excision of their nodal disease. Eur J Cancer 2004;40:212-8.
  15. Gipponi M, Solari N, Di Somma FC, Bertoglio S, Cafiero F. New fields of application of the sentinel lymph node biopsy in the pathologic staging of solid neoplasms: review of the literature and surgical perspectives. J Surg Oncol 2004;85:171-9.
  16. Moore RG, DePasquale SE, Steinhoff MM, GajewskiW, Steller M, Noto R, et al. Sentinel node identification and the ability to detect metastatic tumour to inguinal lymph nodes in squamous cell cancer of the vulva. Gynaecol Oncol 2003;89:475-9.
  17. Spratt J. Groin dissection. J Surg Oncol 2000;73:243-62
  18. Karakousis CP. Ilioinguinal lymph node dissection. Am J Surg 1983;141:299-303.
  19. Baronofsky ID. Technique of inguinal node dissection. Surgery 1948;24:555-67.
  20. Woodhall JP. Radical groin surgery with particular reference to postoperative healing. Surgery 1953;33:886-95.
  21. Tonouchi H, Ohmori Y, Kobayashi M, Konishi N, Tanaka K, Mohri Y, et al. Operative morbidity associated with groin dissections. Surg Today 2004;34:413-8.
  22. Zhang SH, Sood AK, Sorosky JI, Anderson B, Buller RE. Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva. Cancer 2000;89:1520-5.
  23. Paley PJ, Johnson PR, Adcock LL, Cosin JA, Chen MD, Fowler JM, et al. The effect of sartorius transposition on wound morbidity following inguinal-femoral lymphadenectomy. Gynecol Oncol 1997;64:237-41.
  24. Bland KI, Klamer TW, Polk HC Jr, Knutson CO. Isolated regional lymph node dissection: morbidity, mortality and economic considerations. Ann Surg 1981;193:372-6.
  25. Urist MM, Maddox WA, Kennedy JE, Balch CM. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 1983;51:2152-6.

Corresponding Author

Dr P.Sridhar

Dept of Radiation Oncology, Kidwai Cancer Institute, Bengaluru